Prophylaxis of vertical HBV infection

References

• Nelson NP, Jamieson DJ, Murphy TV. Prevention of perinatal hepatitis B virus transmission. J Pediatric Infect Dis Soc. 2014;3 (Suppl 1):S7–S12.
   PubMedGoogle Scholar
• Pan CQ, Duan ZP, Bhamidimarri KR, et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol. 2012;10(5):452–459.
   PubMed Web of Science ®Google Scholar
• Park JS, Pan C. Current recommendations of managing HBV infection in preconception or pregnancy. Front Med. 2014;8(2):158–165.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol. 2012;57(1):167–185.
   PubMed Web of Science ®Google Scholar
• Dunkelberg JC, Berkley EM, Thiel KW, et al. Hepatitis B and C in pregnancy: a review and recommendations for care. J Perinatol. 2014;34(12):882–891.
   PubMed Web of Science ®Google Scholar
• Yi W, Pan CQ, Hao J, et al. Risk of vertical transmission of hepatitis B after amniocentesis in HBs antigen-positive mothers. J Hepatol. 2014;60(3):523–529.
   PubMed Web of Science ®Google Scholar
• Zou H, Chen Y, Duan Z, et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers. J Viral Hepat. 2012;19(2):e18–25.
   PubMed Web of Science ®Google Scholar
• Borgia G, Carleo MA, Gaeta GB, et al. Hepatitis B in pregnancy. World J Gastroenterol. 2012;18(34):4677–4683.
   PubMed Web of Science ®Google Scholar
• Gentile I, Borgia G. Vertical transmission of hepatitis B virus: challenges and solutions. Int J Womens Health. 2014;6:605–611.
   PubMedGoogle Scholar
• Shi Z, Li X, Ma L, et al. Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis. Int J Infect Dis. 2010;14(7):e622–634.
   PubMed Web of Science ®Google Scholar
• Terrault NA, Bzowej NH, Chang KM, et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016;63(1):261–283.
   PubMed Web of Science ®Google Scholar
• Han GR, Cao MK, Zhao W, et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol. 2011;55(6):1215–1221.
   PubMed Web of Science ®Google Scholar
• Shi Z, Yang Y, Ma L, et al. Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis. Obstet Gynecol. 2010;116(1):147–159.
   PubMed Web of Science ®Google Scholar
• Antiviral Pregnancy Registry (APR). Antiviral pregnancy registry interim report 1, January 1989 through 31 January 2012. 2012. Available from: http://APregistry.com
   Google Scholar
• Tran TT. Hepatitis B: treatment to prevent perinatal transmission. Clin Obstet Gynecol. 2012;55(2):541–549.
   PubMedGoogle Scholar
• Han L, Zhang HW, Xie JX, et al. A meta-analysis of lamivudine for interruption of mother-to-child transmission of hepatitis B virus. World J Gastroenterol. 2011;17(38):4321–4333.
   PubMed Web of Science ®Google Scholar
• Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat. 2009;16(2):94–103.
   PubMed Web of Science ®Google Scholar
• Jackson V, Ferguson W, Kelleher TB, et al. Lamivudine treatment and outcome in pregnant women with high hepatitis B viral loads. Eur J Clin Microbiol Infect Dis. 2015;34(3):619–623.
   PubMed Web of Science ®Google Scholar
• Ayres A, Yuen L, Jackson KM, et al. Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations. J Viral Hepat. 2014;21(11):809–817.
   PubMed Web of Science ®Google Scholar
• Pan CQ, Mi LJ, Bunchorntavakul C, et al. Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series. Dig Dis Sci. 2012;57(9):2423–2429.
   PubMed Web of Science ®Google Scholar
• Tsai P-JS, Chang A, Yamada S, et al. Use of tenofovir disoproxil fumarate in highly viremic, hepatitis B mono-infected pregnant women. Dig Dis Sci. 2014;59(11):2797–2803.
   PubMed Web of Science ®Google Scholar
• Greenup AJ, Tan PK, Nguyen V, et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. J Hepatol. 2014;61(3):502–507.
   PubMed Web of Science ®Google Scholar
• Celen MK, Mert D, Ay M, et al. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection. World J Gastroenterol. 2013;19(48):9377–9382.
   PubMed Web of Science ®Google Scholar
• Brown RS Jr, McMahon BJ, Lok ASF, et al. Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis. Hepatology. 2016;63(1):319–333.
   PubMed Web of Science ®Google Scholar
• Brown RS Jr, Verna EC, Pereira MR, et al. Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy Registry. J Hepatol. 2012;57(5):953–959.
   PubMed Web of Science ®Google Scholar
• Yang J, Zeng XM, Men YL, et al. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus – a systematic review. Virol J. 2008;5:100.
   PubMed Web of Science ®Google Scholar
• Hu Y, Chen J, Wen J, et al. Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virus. BMC Pregnancy Childbirth. 2013;13:119.
   PubMed Web of Science ®Google Scholar
• Chang MS, Gavini S, Andrade PC, et al. Caesarean section to prevent transmission of hepatitis B: a meta-analysis. Can J Gastroenterol Hepatol. 2014;28(8):439–444.
   PubMed Web of Science ®Google Scholar
• Xu H, Zeng T, Liu JY, et al. Measures to reduce mother-to-child transmission of hepatitis B virus in China: a meta-analysis. Dig Dis Sci. 2014;59(2):242–258.
   PubMed Web of Science ®Google Scholar
• Liu CP, Zeng YL, Zhou M, et al. Factors associated with mother-to-child transmission of hepatitis B virus despite immunoprophylaxis. Intern Med. 2015;54(7):711–716.
   PubMed Web of Science ®Google Scholar
• Pan CQ, Zou HB, Chen Y, et al. Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants. Clin Gastroenterol Hepatol. 2013;11(10):1349–1355.
   PubMed Web of Science ®Google Scholar
• Visvanathan K, Dusheiko G, Giles M, et al. Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Gut. 2016;65(2):340–350.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Draft global health sector strategy on viral hepatitis, 2016–2021: the first of its kind (draft 13.11.2015). 2015 [cited 2016 Mar15]. Available from: http://​www.​who.​int/​hepatitis/​strategy2016-2021/​Draft_​global_​health_​sector_​strategy_​viral_​hepatitis_​13nov.​pdf?​ua=​1
   Google Scholar
• CDC. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part 1: immunization of infants, children, and adolescents. MMWR 2005 (RR-16). Available from: http://www.cdc.gov/hepatitis/hbv/pdfs/deliveryhospitalpreventperinatalhbvtransmission.pdf.
   Google Scholar
• Ko SC, Schillie SF, Walker T, et al. Hepatitis B vaccine response among infants born to hepatitis B surface antigen-positive women. Vaccine. 2014;32(18):2127–2133.
   PubMed Web of Science ®Google Scholar
• Elefsiniotis IS, Papadakis M, Vlahos G, et al. Clinical significance of hepatitis B surface antigen in cord blood of hepatitis B e-antigen-negative chronic hepatitis B virus-infected mothers. Intervirology. 2009;52(3):132–134.
   PubMed Web of Science ®Google Scholar
• Singh AE, Plitt SS, Osiowy C, et al. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants. J Viral Hepat. 2011;18(7):468–473.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhang S, Luo C, et al. Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China. BMC Infect Dis. 2012;12:221.
   PubMed Web of Science ®Google Scholar
• Song YM, Sung J, Yang S, et al. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus. Eur J Pediatr. 2007;166(8):813–818.
   PubMed Web of Science ®Google Scholar
• Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis. 2007;7(6):402–409.
   PubMed Web of Science ®Google Scholar
• Kourtis AP, Bulterys M, Hu DJ, et al. HIV-HBV coinfection – a global challenge. N Engl J Med. 2012;366(19):1749–1752.
   PubMed Web of Science ®Google Scholar
• Centers for Disease C. Prevention, Advisory Committee on Immunization Practicers (ACIP) recommended immunization schedules for persons aged 0 through 18 years and adults aged 19 years and older – United States, 2013. MMWR Surveill Summ. 2013;62(Suppl 1):1.
   Google Scholar
• Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54(RR–16):1–31.
   PubMedGoogle Scholar
• WHO Publication. Hepatitis B vaccines: WHO position paper – recommendations. Vaccine. 2010;28(3):589–590.
   PubMedGoogle Scholar
• Zou H, Chen Y, Duan Z, et al. Protective effect of hepatitis B vaccine combined with two-dose hepatitis B immunoglobulin on infants born to HBsAg-positive mothers. PLoS One. 2011;6(10):e26748.
   PubMed Web of Science ®Google Scholar
• Lin X, Guo Y, Zhou A, et al. Immunoprophylaxis failure against vertical transmission of hepatitis B virus in the Chinese population: a hospital-based study and a meta-analysis. Pediatr Infect Dis J. 2014;33(9):897–903.
   PubMed Web of Science ®Google Scholar
• Zhang L, Gui X, Wang B, et al. A study of immunoprophylaxis failure and risk factors of hepatitis B virus mother-to-infant transmission. Eur J Pediatr. 2014;173(9):1161–1168.
   PubMed Web of Science ®Google Scholar
• Foaud H, Maklad S, Mahmoud F, et al. Occult hepatitis B virus infection in children born to HBsAg-positive mothers after neonatal passive-active immunoprophylaxis. Infection. 2015;43(3):307–314.
   PubMed Web of Science ®Google Scholar
• Chen HL, Lin LH, Hu FC, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology. 2012;142(4):773–781e2.
   PubMed Web of Science ®Google Scholar
• Society for Maternal-Fetal Medicine (SMFM), Dionne-Odom J, Tita AT, et al. Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission. Am J Obstet Gynecol. 2016;214(1):6–14.
   PubMed Web of Science ®Google Scholar